ÂÜÀòÂÒÂ×

Shravanthi Reddy serves as the CEO of Oculotix since November 2022, focusing on AI solutions that enhance patient satisfaction and surgical efficiency in cataract and refractive surgeries. In addition, Reddy holds the position of COO at both Amaros AI and Visant Medical, Inc., and has been the CEO at ClearSight, which develops advanced intraocular lenses for cataract surgery. Previously, Reddy was the VP of R&D at Sharklet Technologies Inc., where significant funding was secured for innovative technology aimed at preventing device-associated infections. Reddy's early career included a fellowship with the American Association for the Advancement of Science and a research position at the Max Planck Institute for Intelligent Systems. Reddy earned a BSE in Chemical Engineering from Princeton University and a PhD in Chemical Engineering from The University of Texas at Austin.